Iron supplements concomitant with HIF-PHIs in the treatment of CKD anemia

• Главные авторы: Xue Wang (Автор), Cuiting Wei (Автор), Delong Zhao (Автор), Xuefeng Sun (Автор), Fengge Zhu (Автор), Yan Mei (Автор), Qian Ma (Автор), Guangyan Cai (Автор), Xiangmei Chen (Автор), Ping Li (Автор)
• Формат: ‌
• Опубликовано: Karger Publishers, 2023-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Anemia is a common and important complication in patients with chronic kidney disease (CKD). Accordingly, the current treatment is based on erythropoiesis stimulating agents (ESAs) and iron. Hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD) inhibitors (HIF-PHIs) have been developed to t...